Carbon quantum dot-based nanoplatforms for cancer therapy and photodynamic therapy: emerging strategies for targeting cancer and cancer stem cells
- 1Laser Research Centre, University of Johannesburg, Doornfontein Campus Johannesburg South Africa
Abstract
With cancer's rising incidence and mortality rates expected to increase sharply by 2030, cancer continues to be a major worldwide health concern. Drug resistance, non-specific toxicity, and the persistence of cancer stem cells (CSCs), which cause tumor recurrence, metastasis, and therapeutic resistance, frequently limit conventional therapies. Although photodynamic therapy (PDT) provides a less intrusive option, tumor hypoxia, low photosensitizer (PS) selectivity, and restricted light penetration limit its therapeutic usefulness. Because of their remarkable optical characteristics, biocompatibility, adjustable surface chemistry, and inherent photosensitizing powers, carbon quantum dots (CQDs) have become a viable nanoplatform for cancer treatment. This review offers a comprehensive synthesis of current developments in CQD-based PDT for CSC and cancer cell targeting. The principles of PDT, CQD synthesis, and physicochemical characteristics; surface functionalization techniques using targeting ligands and stimuli-responsive moieties; and active targeting methods such as passive (enhanced permeability and retention (EPR) effect), active (ligand–receptor interactions), and organelle-specific targeting are all methodically examined. CQD-based methods for targeting CSC-like populations such as surface-functionalized CQDs for CSC indicators, ROS-mediated apoptosis, ferroptosis induction, and immunogenic cell death, are given particular attention. Highlighted are recent developments in upconversion systems, metal-doped hybrids, near-infrared (NIR)-activated CQDs, and combination treatments. However, direct experimental evidence that supports the efficacy of CQD-mediated PDT against CSCs remains limited, and most studies infer CSC-targeting potential from experiments conducted in cancer cell line. Challenges limiting the application of CQDs such as low quantum yield, tumor hypoxia, long-term biosafety, synthesis standardization, and clinical translation barriers were discussed, alongside emerging trends in personalized nanomedicine, AI-assisted design, and integration with gene therapy.
Related
- Measurement-efficient energy estimator for quantum chemistry of photodynamic materials
- From Mitochondrial Targeting to Microbial Killing: Twinkle-Derived Peptides as an Emerging Class of Potent AMPs
- Chlorate as an emerging contaminant in water and food matrices: Sources, occurrence, toxicity, analytical methods, and mitigation strategies: A critical review
- Nanocarrier-Mediated Immunotherapy for Gynecological Malignancies: Mechanisms, Clinical Translation, and Emerging Nucleic Acid-Based Strategies.
- Advances in Aqueous Electrolyte Engineering: From Fundamental Limitations to Emerging Strategies
BibTeX
@article{kah2026carbon,
title = {{Carbon quantum dot-based nanoplatforms for cancer therapy and photodynamic therapy: emerging strategies for targeting cancer and cancer stem cells}},
author = {Glory Kah and Heidi Abrahamse},
journal = {Nanoscale Advances},
year = {2026},
month = nov,
doi = {10.1039/d6na00732e},
url = {https://doi.org/10.1039/d6na00732e},
note = {CC BY-NC 3.0},
}
RIS
TY - JOUR
TI - Carbon quantum dot-based nanoplatforms for cancer therapy and photodynamic therapy: emerging strategies for targeting cancer and cancer stem cells
AU - Glory Kah
AU - Heidi Abrahamse
PY - 2026
DA - 2026/11/12
JO - Nanoscale Advances
DO - 10.1039/d6na00732e
UR - https://doi.org/10.1039/d6na00732e
AB - With cancer's rising incidence and mortality rates expected to increase sharply by 2030, cancer continues to be a major worldwide health concern. Drug resistance, non-specific toxicity, and the persistence of cancer stem cells (CSCs), which cause tumor recurrence, metastasis, and therapeutic resistance, frequently limit conventional therapies. Although photodynamic therapy (PDT) provides a less intrusive option, tumor hypoxia, low photosensitizer (PS) selectivity, and restricted light penetration limit its therapeutic usefulness. Because of their remarkable optical characteristics, biocompatibility, adjustable surface chemistry, and inherent photosensitizing powers, carbon quantum dots (CQDs) have become a viable nanoplatform for cancer treatment. This review offers a comprehensive synthesis of current developments in CQD-based PDT for CSC and cancer cell targeting. The principles of PDT, CQD synthesis, and physicochemical characteristics; surface functionalization techniques using targeting ligands and stimuli-responsive moieties; and active targeting methods such as passive (enhanced permeability and retention (EPR) effect), active (ligand–receptor interactions), and organelle-specific targeting are all methodically examined. CQD-based methods for targeting CSC-like populations such as surface-functionalized CQDs for CSC indicators, ROS-mediated apoptosis, ferroptosis induction, and immunogenic cell death, are given particular attention. Highlighted are recent developments in upconversion systems, metal-doped hybrids, near-infrared (NIR)-activated CQDs, and combination treatments. However, direct experimental evidence that supports the efficacy of CQD-mediated PDT against CSCs remains limited, and most studies infer CSC-targeting potential from experiments conducted in cancer cell line. Challenges limiting the application of CQDs such as low quantum yield, tumor hypoxia, long-term biosafety, synthesis standardization, and clinical translation barriers were discussed, alongside emerging trends in personalized nanomedicine, AI-assisted design, and integration with gene therapy.
SN - 2516-0230
ER -